Ovarian cancer (OC) represents a significant challenge in the realm of gynecological cancers, characterized by poor survival rates and complex etiology. This review delves into the genetic, environmental, and hormonal factors underpinning OC development, shedding light on both well-established contributors and emerging influences. We reviewed scientific databases searching for OC genetic and epigenetic factors and included studies based on their relevancy. As a result of exploring ovarian carcinogenesis, this systematic review contains data collected from 102 works. The role of prominent genetic players, such as BRCA mutations and DNA repair mechanisms, underscores the intricate landscape of OC susceptibility. Furthermore, we explore Li-Fraumeni and Lynch syndrome, which result in a heightened predisposition to OC development. Hormonal factors such as estrogen, progesterone, and androgens are also discussed in detail. Environmental alterations, ranging from lifestyle influences to microbiome dysbiosis add layers of complexity to OC pathogenesis. Lifestyle factors such as obesity, alcohol consumption, and physical activity intersect with genetic and epigenetic pathways, shaping the risk landscape for OC. This review provides a nuanced understanding of the multifactorial nature of OC through a meticulous examination of current literature, emphasizing the need for holistic approaches to prevention, diagnosis, and treatment.
Cyanobacteria are distributed in diverse environments on Earth. They have evolved to synthesize a variety of secondary metabolites to combat and serve as barriers to protect them from distinct environments. Some of these metabolites and compounds exhibit useful physiological activities and are expected to be applied to a wide range of fields, including medicine, agriculture, food, and the cosmetics industry. Due to their photosynthetic ability, cyanobacteria are promising sources for sustainable production of these useful substances. It is expected that future research will lead to the development and efficient production of new compounds. These resources may provide great benefits to our lives and to the environment. This editorial provides an overview of the ultraviolet (UV)-absorbing substances produced by cyanobacteria and discusses future prospects.
Breast cancer, a prominent form of cancer in women, arises from the inner lining of mammary glands, ducts, and lobules. With an approximate prevalence rate of 1 in 8 women, the standard treatment methods for this condition include the surgical excision of afflicted tissues, chemotherapy, radiation, and hormone therapy. The BCL-2 gene, also known as the B cell lymphoma gene, prevents apoptosis in eukaryotic cells. It is commonly found to be excessively active in many types of malignancies, such as leukemia, carcinomas, and breast cancer. The excessive expression of this gene has a role in the advancement of cancer by inhibiting apoptosis. Recent research emphasizes the function of microRNAs (miRs) in regulating the expression of BCL-2. These miRs can either decrease or increase the activity of specific genes involved in programmed cell death, thus making them potential targets for therapeutic interventions. This review explicitly examines the regulatory impacts of several miRs on BCL-2, thereby investigating their ability to trigger apoptosis and function as targeted treatments for breast cancer. By comprehending the complex interplay between miRs and BCL-2, it is possible to devise novel therapeutic approaches that can augment the efficacy of breast cancer treatments, thus eventually enhancing patient outcomes.
Microalgae have a large high-quality protein content that can be used as human protein supplements. Dunaliella salina and Spirulina platensishave been identified as rich sources of natural bioactive compounds. We aimed to examine the antioxidant properties of bioactive peptides using the enzymatic digestion of the ribulose-1,5-bisphosphate carboxylase/oxygenase (RuBisCO) enzyme derived from D. salina and S. platensismicroalgae. This was an in vitro and in silico study. Cell walls of D. salina and S. platensis were lysed, proteins were isolated, and RuBisCO fraction was concentrated. Then, the protein was enzymatically digested using pepsin, trypsin, and chymotrypsin. Finally, antioxidant activity was assessed at different stages (pre- and post-digestion). The 1,1- diphenyl-2-picrylhydrazyl (DPPH) assay was used to assess the antioxidant potential of hydrolyzates both before and after digestion. Findings indicated that digestion over time, particularly by chymotrypsin, produced bioactive fragments with enhanced antioxidant properties. For the 0–35 protein fraction (which likely includes RuBisCO), the antioxidant potential of peptides derived from S. platensis was significantly greater than that from D. salina. We showed that chymotrypsin may be an appropriate enzyme to yield the highest peptide concentrations from the protein extracts of these microalgae with the highest antioxidant activity. Moreover, the results of digesting the RuBisCO sequence with digestive enzymes showed that antioxidant properties increased with the production of hidden bioactive peptides. This finding may lead to the application of RuBisCO protein and its derivative peptides in the food and pharmaceutical industries of S. platensis and D. salina.
Cancer remains one of the foremost causes of death worldwide. Despite advancements in pharmaceutical therapies, patients continue to experience adverse effects. Consequently, there is a considerable interest in exploring mushrooms as a supplemental cancer treatment. In Asian countries, edible and medicinal mushrooms have long been consumed in both culinary practices and herbal remedies. Their health and nutritional benefits have also garnered rising attention in Europe. Food-grade mushrooms have a variety of pharmacological properties, including soothing and immunomodulating effects, and are associated with abundant therapeutic benefits. The primary mechanisms behind their anticancer activity comprise immune system improvement, cell cycle arrest, regulation of apoptosis, prevention of metastasis, and inhibition of cancer cell growth. Here, we thoroughly review the anticancer activities of several culinary and medicinal mushrooms, as well as some endophytic fungi, with a particular focus on potential bioactive compounds and their molecular mechanisms.
Neural tube defects (NTDs) are common congenital anomalies formed by the incomplete closure of the neural tube during early embryonic development. This study aims to identify potential plasma biomarkers associated with NTDs using an untargeted metabolomics approach, thereby enhancing the understanding of the disease pathogenesis and facilitating early diagnosis. Peripheral venous blood samples were obtained from 21 healthy controls and 20 individuals diagnosed with NTDs. Untargeted metabolomic profiling was performed using Quadrupole Time-of-Flight Liquid Chromatography Mass Spectrometry (Q-TOF LC/MS) in positive ion mode. Data processing was conducted using the XCMS package in R, thus identifying significant metabolites based on a fold change greater than 1.5 and a p-value less than 0.05. The analysis revealed significant alterations in several metabolites in NTD cases compared to the healthy controls. Notably, changes were observed in arachidonic acid and prostaglandins (lipid metabolism), choline (methylation processes), amino acids such as leucine, phenylalanine, and lysine (amino acid metabolism), thyrotropin-releasing hormone, vitamin D3, cob(II)alamin, and galactosylsphingosine (sphingolipid metabolism). The identified metabolites may play a role in the pathogenesis of NTDs and hold potential as early diagnostic biomarkers.